STAY INFORMED ABOUT NF1 PN
To receive the latest updates, tools, and tips about NF1 PN and Koselugo, please provide us with some information about yourself.
KOSELUGO® (selumetinib) is the first and only FDA-approved therapy proven to shrink NF1 PN in pediatric patients
Koselugo is a prescription medicine that is used to treat children 2 years of age and older with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas (PN) that cannot be completely removed by surgery. It is not known if Koselugo is safe and effective in children under 2 years of age.
Connect with a Patient Education Manager (PEM) to get personal one-to-one support and education, even if your loved one is not yet on Koselugo. PEMs are just one of the resources available through OneSource™.
Find your PEMExplore live and virtual events that cover a range of topics that can help in the care of your child with NF1 PN. Registering is simple and free. Get started today.
See eventsTo receive the latest updates, tools, and tips about NF1 PN and Koselugo, please provide us with some information about yourself.
What are the possible side effects of Koselugo?
Koselugo may cause serious side effects, including:
Before taking Koselugo, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription, over-the-counter medicines, vitamins, or herbal supplements. Especially tell your healthcare provider if you are taking aspirin, blood thinners, or other medicines to treat blood clots. Koselugo contains vitamin E, which may increase risk of bleeding.
What should I avoid while taking Koselugo?
Do not drink grapefruit juice, eat grapefruit, or take supplements with grapefruit or St. John’s Wort during treatment.
Most common side effects include: vomiting, stomach-area pain, nausea, dry skin, muscle and bone pain, feeling of tiredness or lacking energy, fever, sores in your mouth, headache, redness around the fingernails, itching.
These are not all the possible side effects of Koselugo. Call your
healthcare provider for medical advice about side effects. Your
healthcare provider may change your dose, temporarily stop, or
permanently ask you to stop taking Koselugo if you have any of
these side effects.
You may report side effects to AstraZeneca at 1-800-236-9933 or
at
https://
us-aereporting.astrazeneca.com
or FDA at
1-800-FDA-1088
or
www.fda.gov/medwatch.
What is Koselugo?
All families shown in this website have been compensated by Alexion, unless otherwise noted.